FDA
approval
· 2024-04-19
FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
Summary
FDA approved a supplemental application for FETZIMA (levomilnacipran hydrochloride) from Allergan, Inc. The action constitutes an additional regulatory authoriz…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for FETZIMA (LEVOMILNACIPRAN HYDROCHLORIDE)